Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospective study

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

Mentioned by

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in World Journal of Gastrointestinal Oncology (July 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.